Redoocs and all, listened to the conference call and am really impressed.
Pretty excited actually.
As for NGIO, I missed the share giveaway in Frbruary, but shareholders of GNBT will still get a shareholder rights offering of NGIO at a discounted price which is awesome.
As for the Type 1 diabetes, Generex Biotechnology Signs Letter of Intent to Acquire 51% in ALTuCELL, Inc. and their Cellular Therapy Product Altsulin® with Patented …
Redoocs if you listen to the Generex CC ALTuCell technology sounds much like the other company only they are using pancreatic ilet cells. Lake Forest University has done extensive work (5 years) with ALTuCell's microencapsulation (sound familiar?) only GNBT is much further along then the other.
So much going on with Generex. Glad I got in. Not much but I am in. Money made is money made. I feel really good about this investment.
News 
Market Data 
Discover 
